HUMANA INC — Director's Dealing 2020

Nov 6, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HUMANA INC (HUM)
CIK: 0000049071
Period of Report: 2020-11-04

Reporting Person: Wheatley Timothy Alan (Segment President, Retail)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-11-04	Humana Common	M	10914	$217.415	Acquired	18803	Direct
2020-11-04	Humana Common	M	2207	$268.47	Acquired	21010	Direct
2020-11-04	Humana Common	S	13121	$446.4254	Disposed	7889	Direct
2020-11-04	Humana Common	S	2138	$449.4824	Disposed	5751	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-11-04	Options	$217.415	M	10914	Disposed	2024-03-08	Humana Common (10914)	Direct
2020-11-04	Options	$268.47	M	2207	Disposed	2025-02-19	Humana Common (2207)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Humana Common	911	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Options	$271.14	2025-03-01	Humana Common (928)	928	Direct
Options	$307.965	2026-02-25	Humana Common (7902)	7902	Direct
Options	$350.7875	2027-02-24	Humana Common (8595)	8595	Direct
Restricted Stock Units	$		Humana Common (513)	513	Direct
Restricted Stock Units	$		Humana Common (108)	108	Direct
Restricted Stock Units	$		Humana Common (1191)	1191	Direct
Restricted Stock Units	$		Humana Common (1710)	1710	Direct
Phantom Stock Units	$		Humana Common (138)	138	Indirect

Footnotes

F1: Shares held for the benefit of reporting person as of October 31, 2020 under the Humana Retirement Savings Plan including routine payroll deductions, quarterly dividend allocation, and a routine disposition of shares to fund an administrative fee assessment under a Tax-Conditioned Plan, exempt under Rule 16b-3(c).

F2: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 03/08/2017. 12,998 options vesting in three annual increments, and 7,499 options fully vest three years from the date of grant.

F3: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Non-Qualified stock options granted to reporting person on 02/19/2018, vesting in three increments from 02/19/2019 to 02/19/2021.

F4: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Non-Qualified stock options granted to reporting person on 02/25/2019, vesting in three increments from 2/25/20 to 2/25/22.

F5: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Non-Qualified stock options granted to reporting person on 03/1/2018, vesting in three increments from 3/1/19 to 3/1/21.

F6: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2020, vesting in three annual increments from 2/24/21 to 2/24/23.

F7: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F8: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F9: Restricted stock units granted to reporting person on 02/19/18, 33% of the award is vesting on 12/15/18, 12/15/19 and 12/15/20.

F10: Restricted stock units granted to reporting person on 03/1/18, 33% of the award is vesting on 12/15/18, 12/15/19 and 12/15/20.

F11: Restricted stock units granted to reporting person on 02/25/19, 33% of the award is vesting on 12/15/19, 12/15/20 and 12/15/21.

F12: Restricted stock units granted to reporting person on 02/24/2020, 33% of the award is vesting on 12/15/20, 12/15/21, and 12/15/22.

F13: Phantom Stock Units held for the benefit of reporting person as of October 31, 2020 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price.

F14: Shares sold at prices ranging from $445.09 to $448.11. Price reported is weighted average sales price.

F15: All shares sold at reported price.